Literature DB >> 12914926

Functional homology between yeast piD261/Bud32 and human PRPK: both phosphorylate p53 and PRPK partially complements piD261/Bud32 deficiency.

Sonia Facchin1, Raffaele Lopreiato, Maria Ruzzene, Oriano Marin, Geppo Sartori, Claudia Götz, Mathias Montenarh, Giovanna Carignani, Lorenzo A Pinna.   

Abstract

Yeast piD261/Bud32 belongs to the piD261 family of atypical protein kinases structurally conserved, from Archaea to human. The disruption of its gene is causative of severely defective growth. Its human homologue, PRPK, interacts with and phosphorylates the oncosuppressor p53 protein, which is lacking in yeast. Here we show that on one hand piD261/Bud32 interacts with and phosphorylates human p53 in vitro, on the other hand PRPK can partially complement the phenotype of yeast lacking the gene encoding piD261/Bud32. These data indicate that, despite considerable structural divergence, members of the piD261 family from distantly related organisms display a remarkable functional conservation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914926     DOI: 10.1016/s0014-5793(03)00770-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Yeast homolog of a cancer-testis antigen defines a new transcription complex.

Authors:  Elena Kisseleva-Romanova; Raffaele Lopreiato; Agnès Baudin-Baillieu; Jean-Claude Rousselle; Laila Ilan; Kay Hofmann; Abdelkader Namane; Carl Mann; Domenico Libri
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

2.  Downward causation by information control in micro-organisms.

Authors:  Luc Jaeger; Erin R Calkins
Journal:  Interface Focus       Date:  2011-09-29       Impact factor: 3.906

3.  Identification of TP53RK-Binding Protein (TPRKB) Dependency in TP53-Deficient Cancers.

Authors:  Moloy T Goswami; Kelly R VanDenBerg; Sumin Han; Lei Lucy Wang; Bhavneet Singh; Travis Weiss; Myles Barlow; Steven Kamberov; Kari Wilder-Romans; Daniel R Rhodes; Felix Y Feng; Scott A Tomlins
Journal:  Mol Cancer Res       Date:  2019-05-20       Impact factor: 5.852

Review 4.  Post-translation modification in Archaea: lessons from Haloferax volcanii and other haloarchaea.

Authors:  Jerry Eichler; Julie Maupin-Furlow
Journal:  FEMS Microbiol Rev       Date:  2012-12-20       Impact factor: 16.408

5.  Structure of the archaeal Kae1/Bud32 fusion protein MJ1130: a model for the eukaryotic EKC/KEOPS subcomplex.

Authors:  Arnaud Hecker; Raffaele Lopreiato; Marc Graille; Bruno Collinet; Patrick Forterre; Domenico Libri; Herman van Tilbeurgh
Journal:  EMBO J       Date:  2008-09-03       Impact factor: 11.598

6.  Analysis of the interaction between piD261/Bud32, an evolutionarily conserved protein kinase of Saccharomyces cerevisiae, and the Grx4 glutaredoxin.

Authors:  Raffaele Lopreiato; Sonia Facchin; Geppo Sartori; Giorgio Arrigoni; Stefano Casonato; Maria Ruzzene; Lorenzo A Pinna; Giovanna Carignani
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

Review 7.  Protein Ser/Thr/Tyr phosphorylation in the Archaea.

Authors:  Peter J Kennelly
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

8.  Targeting PRPK Function Blocks Colon Cancer Metastasis.

Authors:  Tatyana Zykova; Feng Zhu; Lei Wang; Haitao Li; Do Young Lim; Ke Yao; Eunmiri Roh; Sang-Pil Yoon; Hong-Gyum Kim; Ki Beom Bae; Weihong Wen; Seung Ho Shin; Janos Nadas; Yan Li; Weiya Ma; Ann M Bode; Zigang Dong
Journal:  Mol Cancer Ther       Date:  2018-02-26       Impact factor: 6.261

9.  Plant and animal pathogen recognition receptors signal through non-RD kinases.

Authors:  Christopher Dardick; Pamela Ronald
Journal:  PLoS Pathog       Date:  2006-01-20       Impact factor: 6.823

10.  The human EKC/KEOPS complex is recruited to Cullin2 ubiquitin ligases by the human tumour antigen PRAME.

Authors:  Adalberto Costessi; Nawel Mahrour; Vikram Sharma; Rieka Stunnenberg; Marieke A Stoel; Esther Tijchon; Joan W Conaway; Ronald C Conaway; Hendrik G Stunnenberg
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.